Title of article
A new anti-ErbB2 strategy in the treatment of cancer: Prevention of ligand-dependent ErbB2 receptor heterodimerization
Author/Authors
Baselga، نويسنده , , Jose، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2002
Pages
3
From page
93
To page
95
Abstract
Preventing ligand-dependent ErbB2 receptor heterodimers by an anti-ErbB2 monoclonal antibody shuts down receptor signaling and has potent antitumor activity even in tumors that express low levels of ErbB2, a finding that could result in a larger number of patients benefiting from anti-ErbB2 therapies.
Journal title
Cancer Cell
Serial Year
2002
Journal title
Cancer Cell
Record number
1334893
Link To Document